By Counterforce Health Team in Uptravi (selexipag) —

Work With Your Doctor to Get Uptravi (Selexipag) Covered by Humana in Florida: Complete Guide 2025

Answer Box: Getting Uptravi (Selexipag) Covered by Humana in Florida

Humana requires prior authorization for Uptravi (selexipag) in Florida Medicare Advantage plans. Success requires WHO Group I PAH confirmation via right heart catheterization, documented functional class II-III status, and evidence of background therapy with ERA/PDE5i. Your first step: schedule a visit with your PAH specialist to review hemodynamic data and gather required documentation. Submit PA through Humana's provider portal or fax to 877-486-2621. Standard decisions take 7 days; expedited reviews for urgent cases process within 72 hours.

Table of Contents

  1. Set Your Goal: What Approval Requires
  2. Visit Preparation: Building Your Case
  3. Evidence Kit: Required Documentation
  4. Medical Necessity Letter Structure
  5. Peer-to-Peer Review Support
  6. After-Visit Action Items
  7. Respectful Persistence Strategy
  8. Appeals Process for Florida Patients
  9. FAQ: Common Questions

Set Your Goal: What Approval Requires

Uptravi (selexipag) approval through Humana hinges on meeting specific clinical criteria that align with FDA labeling and PAH treatment guidelines. Your partnership with your provider is essential—they hold the clinical expertise while you contribute the insurance navigation knowledge.

Coverage Requirements at a Glance

Requirement What It Means Documentation Needed
WHO Group I PAH diagnosis Confirmed via right heart catheterization mPAP >20 mmHg, PVR >2 WU, PAWP ≤15 mmHg
Functional Class II-IV Symptom severity assessment WHO/NYHA functional class documentation
Background therapy Prior/concurrent ERA or PDE5i treatment Medication history, dosing, tolerability
Risk stratification Multiparameter assessment 6-minute walk test, NT-proBNP, echo results

Source: Humana Prior Authorization Lists

Partnership Framework

Your role focuses on insurance logistics: understanding Humana's requirements, tracking deadlines, and ensuring complete submission. Your provider's role centers on clinical justification: documenting diagnosis, treatment rationale, and medical necessity. This collaboration maximizes approval chances while respecting each person's expertise.

Visit Preparation: Building Your Case

Arrive at your appointment with organized information that helps your provider craft a compelling prior authorization request.

Symptom Timeline Documentation

Create a chronological record of your PAH progression:

  • Date of initial symptoms and functional limitations
  • Specific activities that trigger shortness of breath or fatigue
  • Changes in exercise tolerance over time
  • Impact on daily activities and quality of life

Treatment History Summary

Compile your complete PAH medication history:

  • Current medications: ERA (ambrisentan, bosentan) and PDE5i (sildenafil, tadalafil) with doses
  • Previous therapies: What you've tried, duration, reasons for discontinuation
  • Side effects experienced: Document intolerances that limit other options
  • Response to treatment: Functional improvements or lack thereof

Functional Impact Notes

Track concrete examples of limitation:

  • Distance you can walk before becoming short of breath
  • Stairs you can climb without stopping
  • Activities you've had to modify or stop
  • Sleep disruption from symptoms
Tip: Keep a brief symptom diary for 1-2 weeks before your visit. Note specific activities and symptoms to provide concrete examples for your provider's documentation.

Evidence Kit: Required Documentation

Your provider needs specific clinical evidence to support Uptravi approval. Help them gather complete documentation by understanding what Humana requires.

Essential Clinical Data

Hemodynamic Confirmation:

  • Right heart catheterization results showing mean pulmonary artery pressure >20 mmHg
  • Pulmonary vascular resistance >2 Wood Units
  • Pulmonary artery wedge pressure ≤15 mmHg
  • Exclusion of other causes (Groups 2-5 pulmonary hypertension)

Functional Assessment:

  • WHO/NYHA functional class (II-IV typically required)
  • 6-minute walk distance with recent results
  • NT-proBNP or BNP levels for risk stratification
  • Echocardiogram showing right heart strain

Treatment Context:

  • Documentation of background therapy with ERA and/or PDE5i
  • Evidence of inadequate response to dual therapy
  • Contraindications to alternative treatments

Supporting Guidelines

Your provider should reference established treatment recommendations:

  • 2022 ESC/ERS Guidelines supporting sequential triple therapy
  • FDA labeling for Uptravi indicating delay of disease progression
  • PAH risk assessment tools (REVEAL 2.0) showing intermediate-high risk

Medical Necessity Letter Structure

A well-structured medical necessity letter significantly improves approval odds. Share this framework with your provider to ensure comprehensive documentation.

Clinician Corner: Letter Checklist

Opening Statement:

  • Patient demographics and Humana member ID
  • Clear diagnosis: "WHO Group I Pulmonary Arterial Hypertension"
  • Request: "Prior authorization for Uptravi (selexipag) 200 mcg tablets"

Clinical Justification:

  1. Diagnosis confirmation with RHC data and dates
  2. Current functional status (WHO class, 6MWT distance, symptoms)
  3. Treatment history including background ERA/PDE5i therapy
  4. Rationale for Uptravi citing GRIPHON trial data and guidelines
  5. Monitoring plan for titration and safety assessment

Risk of Delay:

  • Potential for disease progression without treatment intensification
  • Increased hospitalization risk based on current functional status
  • Limited alternative options given patient's treatment history

References:

  • FDA prescribing information for Uptravi
  • 2022 ESC/ERS PAH Guidelines (Class I, Level B recommendation)
  • GRIPHON trial (40% reduction in morbidity/mortality endpoint)

Peer-to-Peer Review Support

If Humana requests peer-to-peer review, you can support your provider's preparation and availability.

Offering Availability Windows

Coordinate with your provider's office to identify optimal times for peer-to-peer calls:

  • Provide your schedule flexibility for urgent reviews
  • Offer to be available for three-way calls if permitted
  • Ensure your provider has current contact information

Case Summary Preparation

Help your provider prepare a concise case summary:

  • One-page overview of diagnosis, current treatment, and Uptravi rationale
  • Key data points readily accessible (RHC results, functional class, 6MWT)
  • Anticipated questions about alternative therapies and their limitations

Counterforce Health specializes in transforming insurance denials into evidence-backed appeals by identifying denial reasons and crafting targeted rebuttals aligned with payer policies. Their platform helps patients, clinicians, and specialty pharmacies navigate complex prior authorization requirements by pulling relevant citations and weaving them into compelling medical necessity arguments.

After-Visit Action Items

Document your visit outcomes and maintain organized records for potential appeals.

What to Save

Clinical Documentation:

  • Copy of medical necessity letter submitted to Humana
  • Lab results, imaging reports, and hemodynamic data referenced
  • Treatment timeline and medication history summary
  • Notes about discussion of alternative therapies

Insurance Communications:

  • Prior authorization submission confirmation
  • Humana reference numbers and submission dates
  • Any initial responses or requests for additional information

Portal Messaging Strategy

Use your patient portal effectively:

  • Message timing: Follow up 5-7 days after PA submission
  • Content focus: Ask for submission status, not clinical decisions
  • Documentation: Save portal messages as PDFs for your records

Respectful Persistence Strategy

Maintain appropriate follow-up without overwhelming your provider's office.

Update Cadence

Week 1: Confirm PA submission and Humana reference number Week 2: Check status if no response from Humana Week 3: Prepare for potential appeal if denial received Beyond: Follow appeal timelines strictly (65 days for Medicare Part D)

Escalation Approach

If your provider seems overwhelmed by insurance requirements:

  • Offer to research Humana's specific criteria yourself
  • Suggest connecting with Counterforce Health for appeal support
  • Provide organized documentation to minimize their administrative burden
  • Respect their clinical judgment while advocating for coverage

Appeals Process for Florida Patients

If Humana denies your initial prior authorization, Florida patients have specific appeal rights and timelines.

Internal Appeal (Redetermination)

Timeline: 65 days from denial notice date Decision timeframe: 7 calendar days (standard) or 72 hours (expedited) Submission methods:

  • Online: Humana member portal
  • Phone: Number on your denial letter
  • Mail: Address provided in denial notice

Expedited Appeals

Request expedited review when waiting for standard decision may jeopardize your health:

  • Your doctor must support the urgency request
  • Humana must respond within 72 hours
  • Applies when PAH symptoms are worsening rapidly

External Review (Florida)

If internal appeal fails:

  • Timeline: 4 months after final internal denial
  • Process: Contact Florida Department of Financial Services at 1-877-693-5236
  • Cost: No charge to consumer
  • Decision: Binding on Humana if reviewer overturns denial

FAQ: Common Questions

How long does Humana prior authorization take in Florida? Standard decisions within 7 calendar days; expedited reviews within 72 hours for urgent medical needs. New enrollees have 90-day PA exemption for ongoing treatments started before enrollment.

What if Uptravi is non-formulary on my plan? Request formulary exception through the same prior authorization process. Your provider must demonstrate medical necessity and that formulary alternatives are inappropriate.

Can I request expedited appeal if my symptoms worsen? Yes, if your doctor determines that waiting for standard review may seriously jeopardize your health. Explicitly request expedited status in your appeal.

Does step therapy apply if I've tried similar drugs outside Florida? Treatment history from any location counts toward step therapy requirements. Ensure your provider documents all prior PAH therapies with dates and outcomes.

What happens if Humana doesn't respond within 7 days? Your appeal automatically escalates to an Independent Review Entity per CMS regulations. Contact Humana to confirm escalation status.

How much does Uptravi cost without insurance? Retail prices typically range $9,000-$25,000 for a 30-day supply. Check manufacturer programs and foundation grants for financial assistance options.

Can my specialty pharmacy help with the prior authorization? Yes, many specialty pharmacies have dedicated PA teams. Coordinate between your provider and pharmacy to avoid duplicate submissions.

What if I need Uptravi while traveling in Florida? Humana covers medically necessary treatments nationwide. Ensure you have adequate supply and carry documentation of your PAH diagnosis when traveling.

This guide provides educational information about insurance coverage processes and should not replace medical advice from your healthcare provider. Coverage decisions depend on individual medical circumstances and specific insurance plan terms.

Sources & Further Reading

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.